Difference between revisions of "Jones John G"
From Bioblast
Beno Marija (talk | contribs) (Created page with "{{Person}}") |
Beno Marija (talk | contribs) |
||
(11 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
{{Person}} | {{EAGLE | ||
|COST = Member | |||
|COST WG3=WG3 | |||
}} | |||
{{Person | |||
|lastname=Jones | |||
|firstname=John G | |||
|title=Prof. Dr. | |||
|institution=Metabolic Control Group Leader | |||
UC-Biotech | |||
Biocant Park, PT | |||
|area code=3004-504 | |||
|city=Coimbre | |||
|country=Portugal | |||
}} | |||
{{Labelingperson}} | |||
== Participated at == | |||
::::* [[MiP2019/MitoEAGLE Belgrade RS|MitoEAGLE 2019 Belgrade RS]] | |||
::::* [[MiPschool Coimbra 2019|MiP/MitoEAGLE Training School 2019 Coimbra PT]] |
Latest revision as of 14:21, 28 September 2020
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Jones John G
MitoPedia topics: EAGLE
COST: Member
COST WG3: WG3
Name | Jones John G, Prof. Dr. |
---|---|
Institution | Metabolic Control Group Leader
UC-Biotech Biocant Park, PT |
Address | , 3004-504 |
City | Coimbre |
State/Province | |
Country | Portugal |
[email protected] | |
Weblink | |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
BEC 2020.1 doi10.26124bec2020-0001.v1 | 2020 | Gnaiger E et al ― MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1 |
Schneeberger 2015 Cell Rep | 2015 | Schneeberger M, Gómez-Valadés AG, Altirriba J, Sebastián D, Ramírez S, Garcia A, Esteban Y, Drougard A, Ferrés-Coy A, Bortolozzi A, Garcia-Roves PM, Jones JG, Manadas B, Zorzano A, Gomis R, Claret M (2015) Reduced α-MSH Underlies Hypothalamic ER-Stress-Induced Hepatic Gluconeogenesis. Cell Rep 12(3):361-70. |
Abstracts
Published | Reference | |
---|---|---|
Jones 2019 MiP2019 | 2019 | Role of mitochondria in altered metabolic fluxes in non-alcoholic fatty liver disease. |